Benitec Biopharma Ltd ADR (BNTC)

NASDAQ
0.320
-0.005(-1.41%)
After Hours
0.363
+0.043(+13.261%)
- Real-time Data
  • Volume:
    155,788
  • Day's Range:
    0.312 - 0.348
  • 52 wk Range:
    0.301 - 3.900
Unusual Post-Market activity

Post-market activity occurs after regular market hours and can be used to judge market strength and direction. Post-market trading has some risk because of lower liquidity and more volatility than regular sessions.

BNTC Overview

Prev. Close
0.325
Day's Range
0.312-0.348
Revenue
80K
Open
0.325
52 wk Range
0.301-3.9
EPS
-2.23
Volume
155,788
Market Cap
8.27M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,392,425
P/E Ratio
-0.305
Beta
1.25
1-Year Change
-91.72%
Shares Outstanding
25,809,533
Next Earnings Date
15 Nov 2022
What is your sentiment on Benitec Biopharma ADR?
or
Market is currently closed. Voting is open during market hours.

Benitec Biopharma Ltd ADR News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Benitec Biopharma Ltd ADR Analysis

Benitec Biopharma Ltd ADR Company Profile

Benitec Biopharma Ltd ADR Company Profile

Employees
0

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell